» Articles » PMID: 10970879

Targeting of Ikaros to Pericentromeric Heterochromatin by Direct DNA Binding

Overview
Journal Genes Dev
Specialty Molecular Biology
Date 2000 Sep 6
PMID 10970879
Citations 100
Authors
Affiliations
Soon will be listed here.
Abstract

Ikaros is a sequence-specific DNA-binding protein that is essential for lymphocyte development. Little is known about the molecular function of Ikaros, although recent results have led to the hypothesis that it recruits genes destined for heritable inactivation to foci containing pericentromeric heterochromatin. To gain further insight into the functions of Ikaros, we have examined the mechanism by which it is targeted to centromeric foci. Efficient targeting of Ikaros was observed upon ectopic expression in 3T3 fibroblasts, demonstrating that lymphocyte-specific proteins and a lymphoid nuclear architecture are not required. Pericentromeric targeting did not result from an interaction with the Mi-2 remodeling factor, as only a small percentage of Mi-2 localized to centromeric foci in 3T3 cells. Rather, targeting was dependent on the amino-terminal DNA-binding zinc finger domain and carboxy-terminal dimerization domain of Ikaros. The carboxy-terminal domain was required only for homodimerization, as targeting was restored when this domain was replaced with a leucine zipper. Surprisingly, a detailed substitution mutant analysis of the amino-terminal domain revealed a close correlation between DNA-binding and pericentromeric targeting. These results show that DNA binding is essential for the pericentromeric localization of Ikaros, perhaps consistent with the presence of Ikaros binding sites within centromeric DNA repeats. Models for the function of Ikaros that are consistent with this targeting mechanism are discussed.

Citing Articles

IKAROS Family Transcription Factors in Lymphocyte Differentiation and Function.

Kastner P, Chan S Adv Exp Med Biol. 2024; 1459:33-52.

PMID: 39017838 DOI: 10.1007/978-3-031-62731-6_2.


Multifaceted roles of gene, perspectives from bench to bedside.

Feng L, Zhang H, Liu T Front Oncol. 2024; 14:1383419.

PMID: 38978740 PMC: 11228169. DOI: 10.3389/fonc.2024.1383419.


Identification and Functional Analysis of a de novo IKZF3 Mutation in a Pediatric Patient with Combined Immunodeficiency.

Shi X, Cao X, Huang M, Zhang P, Yang G, Ren A J Clin Immunol. 2024; 44(5):117.

PMID: 38758229 DOI: 10.1007/s10875-024-01706-9.


Disease-associated AIOLOS variants lead to immune deficiency/dysregulation by haploinsufficiency and redefine AIOLOS functional domains.

Kuehn H, Sakovich I, Niemela J, Gil Silva A, Stoddard J, Polyakova E J Clin Invest. 2023; 134(3).

PMID: 38015619 PMC: 10836806. DOI: 10.1172/JCI172573.


Ikaros is a principal regulator of Aire mTEC homeostasis, thymic mimetic cell diversity, and central tolerance.

Sin J, Sucharov J, Kashyap S, Wang Y, Proekt I, Liu X Sci Immunol. 2023; 8(88):eabq3109.

PMID: 37889983 PMC: 11433069. DOI: 10.1126/sciimmunol.abq3109.


References
1.
Wiens G, Sorger P . Centromeric chromatin and epigenetic effects in kinetochore assembly. Cell. 1998; 93(3):313-6. DOI: 10.1016/s0092-8674(00)81157-5. View

2.
Guex N, Peitsch M . SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis. 1998; 18(15):2714-23. DOI: 10.1002/elps.1150181505. View

3.
Avitahl N, Winandy S, Friedrich C, Jones B, Ge Y, Georgopoulos K . Ikaros sets thresholds for T cell activation and regulates chromosome propagation. Immunity. 1999; 10(3):333-43. DOI: 10.1016/s1074-7613(00)80033-3. View

4.
Csink A, Henikoff S . Something from nothing: the evolution and utility of satellite repeats. Trends Genet. 1998; 14(5):200-4. DOI: 10.1016/s0168-9525(98)01444-9. View

5.
Benson T, Pabo C . High-resolution structures of variant Zif268-DNA complexes: implications for understanding zinc finger-DNA recognition. Structure. 1998; 6(4):451-64. DOI: 10.1016/s0969-2126(98)00047-1. View